The latest research study “Pneumonia Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global pneumonia testing market reached a value of US$ XX Million in 2021. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2022-2027.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/pneumonia-testing-market/requestsample
Pneumonia is a lower respiratory tract infection induced by viruses, bacteria, and fungi. It spreads when one inhales the airborne droplets from the cough or sneeze of an infected person. Pneumonia causes shortness of breath, inflammation in the air sacs of the lungs, mild fever, headaches, dry cough, fatigue, chills, chest pain, etc., and reduces appetite. It can be diagnosed only through a detailed physical examination, such as chest X-ray, medical history review, pulse oximetry, blood and sputum culture, bronchoscopy, fluid sample, etc. Consequently, pneumonia testing is widely adopted in hospitals, diagnostic laboratories, and other healthcare facilities across the globe.
COVID-19Impact on Market: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Pneumonia Testing Market Trends and Drivers:
The rising usage of Point of Care (PoC) Testing and the increasing adoption of Enzyme-Linked Immunosorbent Assay (ELISA) are primarily driving the pneumonia testing market. Additionally, the development of pneumococcal urinary antigen (UAT), immunochromatographic, and advanced nucleic acid detection is also catalyzing the market growth.
Moreover, the expanding geriatric population and the inflating awareness among individuals towards the advantages of early diagnosis of the infection are acting as significant growth-inducing factors.
Besides this, the escalating number of new diagnostic product launches by the key players is anticipated to augment the pneumonia testing market over the forecasted period.
Global Pneumonia Testing Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Pneumonia Testing Companies:
Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Curetis GmbH (OpGen), DiaSorin S.p.A., Hologic Inc, Meridian Bioscience Inc, Quest Diagnostics Incorporated, Quidel Corporation, Roche Holding AG, and Thermo Fisher Scientific Inc.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pneumonia-testing-market
The report has segmented the market on the basis of region, type, method, technology and end user.
Breakup by Type:
Breakup by Method:
- Molecular Diagnostics
- Point of Care Testing
Market Breakup by Technology:
- Enzyme-linked Immunosorbent Assay
- Western Blot
- Polymerase Chain Reaction
Breakup by End User:
- Diagnostic Laboratories
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800